Project Grant R43OD037622
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$324K
Funding Federal Agency
National Institute of General Medical Sciences
Awarding Federal Agency
Aggregate Financial Assistance Data
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98168, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $349,816 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Narwhal Bio, Inc. in San Diego, CA. The grant supports the development of a prototype instrument, software, and consumable for non-invasive live-cell identification, tagging, and downstream characterization. This novel platform aims to enable researchers to study clinically relevant cell-cell interactions that drive diseases like...
The National Institute of General Medical Sciences (NIGMS) awarded a $275,756 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Rewire Neuroscience LLC, a woman-owned small business in Oregon. The funding supports the development of PipSqueak Pro, an AI-powered computer vision platform that aims to democratize access to advanced machine learning techniques for automated biomedical image analysis. The platform seeks to reduce human bias, subjectivity,...
The National Institute of General Medical Sciences (NIGMS) awarded a $675,609 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to Ometa Labs LLC, a minority-owned small business based in Carlsbad, CA. The grant supports the development of a bioinformatics platform for large-scale untargeted metabolomics analysis. The project will run from August 1, 2025 to July 31, 2027, with the goal of advancing fundamental scientific understanding,...
The National Institute of General Medical Sciences (NIGMS) awarded a $300,518 Project Grant under CFDA Program 93.859 (Biomedical Research and Research Training) to E&E Bioclub LLC in Indianapolis, IN. The project aims to develop an all-in-one platform for intracellular overproduction of long, single-strand mRNA. This is intended to address challenges with current mRNA manufacturing methods, such as the cost and scalability constraints of in vitro transcription and the difficulty in...
The National Institute of General Medical Sciences (NIGMS) awarded a $218,622 Project Grant to Vitan-Biotech LLC on September 22, 2023 under the Biomedical Research and Research Training program (CFDA 93.859). The grant will fund the development of an integrated pipeline to rapidly discover and characterize selective, high-affinity nanobodies against defined G protein-coupled receptors (GPCRs) that are important for neurological disorders like schizophrenia, pain, Parkinson's, Alzheimer's, and...
The National Institute of General Medical Sciences (NIGMS) awarded a $298,530 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Epigenter, LLC in Providence, RI. The goal of this 1-year award, effective July 1, 2025, is to develop and characterize "self-delivering" epigenetic editor proteins that can modulate gene expression by targeted DNA demethylation, without requiring genetic transduction. The project will compare two different protein...
The National Institute of General Medical Sciences (NIGMS) awarded a $306,710 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Z Biotech, LLC to develop a glycan binding protein (GBP)-based glycosylation analysis system. The project aims to address limitations in current glycan structure analysis methods by: Collecting a large glycan array dataset to improve prediction of glycan binding affinities; Expanding coverage of glycan epitopes by supplementing with additional...
The National Institute of General Medical Sciences (NIGMS) awarded a $406,250 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, with a performance period from January 22, 2025 to December 31, 2029. The grant aims to develop new chemistries and engineering approaches to manipulate the dynamic nascent extracellular matrix within complex...
The National Institute of General Medical Sciences (NIGMS) awarded a $304,862 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Edvotek Inc., a for-profit company located in Washington, DC. The grant supports the development of the StemFluidics Platform, an innovative microfluidics system designed to enable safe and reproducible hands-on experiments for students to explore biotechnology concepts in classroom settings. The StemFluidics Platform features an...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,061,192 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Genetivision Corporation in Stafford, TX. The grant, which runs from July 2025 to June 2027, will fund the generation, validation, and maintenance of 2,400 conditional loss- and gain-of-function alleles for over 1,200 highly conserved Drosophila genes. This new collection of precisely controllable genetic tools will enable researchers to...